130 related articles for article (PubMed ID: 9272618)
21. Hepatic uptake of chylomicron remnants.
Cooper AD
J Lipid Res; 1997 Nov; 38(11):2173-92. PubMed ID: 9392416
[TBL] [Abstract][Full Text] [Related]
22. Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal.
Windler EE; Greeve J; Daerr WH; Greten H
Biochem J; 1988 Jun; 252(2):553-61. PubMed ID: 3415673
[TBL] [Abstract][Full Text] [Related]
23. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants.
Rohlmann A; Gotthardt M; Hammer RE; Herz J
J Clin Invest; 1998 Feb; 101(3):689-95. PubMed ID: 9449704
[TBL] [Abstract][Full Text] [Related]
24. Use of gene-manipulated models to study the physiology of lipid transport.
Mortimer BC; Martins I; Zeng BJ; Redgrave TG
Clin Exp Pharmacol Physiol; 1997; 24(3-4):281-5. PubMed ID: 9131298
[TBL] [Abstract][Full Text] [Related]
25. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.
Choi SY; Fong LG; Kirven MJ; Cooper AD
J Clin Invest; 1991 Oct; 88(4):1173-81. PubMed ID: 1918372
[TBL] [Abstract][Full Text] [Related]
26. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver.
de Faria E; Fong LG; Komaromy M; Cooper AD
J Lipid Res; 1996 Jan; 37(1):197-209. PubMed ID: 8820115
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein binding to cultured human hepatoma cells.
Krempler F; Kostner GM; Friedl W; Paulweber B; Bauer H; Sandhofer F
J Clin Invest; 1987 Aug; 80(2):401-8. PubMed ID: 3038957
[TBL] [Abstract][Full Text] [Related]
28. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver.
Windler E; Greeve J; Robenek H; Rinninger F; Greten H; Jäckle S
Hepatology; 1996 Aug; 24(2):344-51. PubMed ID: 8690403
[TBL] [Abstract][Full Text] [Related]
29. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice.
Martins IJ; Hone E; Chi C; Seydel U; Martins RN; Redgrave TG
J Lipid Res; 2000 Feb; 41(2):205-13. PubMed ID: 10681404
[TBL] [Abstract][Full Text] [Related]
30. Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both.
Ishibashi S; Perrey S; Chen Z; Osuga Ji; Shimada M; Ohashi K; Harada K; Yazaki Y; Yamada N
J Biol Chem; 1996 Sep; 271(37):22422-7. PubMed ID: 8798405
[TBL] [Abstract][Full Text] [Related]
31. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.
Shimano H; Namba Y; Ohsuga J; Kawamura M; Yamamoto K; Shimada M; Gotoda T; Harada K; Yazaki Y; Yamada N
J Clin Invest; 1994 May; 93(5):2215-23. PubMed ID: 8182153
[TBL] [Abstract][Full Text] [Related]
32. Beta-migrating very-low-density lipoproteins and chylomicron remnants bind to rat liver hepatocytes at a low-density-lipoprotein-receptor-independent site (the remnant receptor).
Van Berkel JC; Voorschuur A; Kuiper J
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):359-60. PubMed ID: 7646469
[No Abstract] [Full Text] [Related]
33. Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake.
Mahley RW; Hui DY; Innerarity TL; Beisiegel U
Arteriosclerosis; 1989; 9(1 Suppl):I14-8. PubMed ID: 2536272
[TBL] [Abstract][Full Text] [Related]
34. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
[TBL] [Abstract][Full Text] [Related]
35. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
36. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.
Beisiegel U; Weber W; Ihrke G; Herz J; Stanley KK
Nature; 1989 Sep; 341(6238):162-4. PubMed ID: 2779654
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the components of the chylomicron remnant removal mechanism by use of the isolated perfused mouse liver.
Yu KC; Jiang Y; Chen W; Cooper AD
J Lipid Res; 1999 Oct; 40(10):1899-910. PubMed ID: 10508210
[TBL] [Abstract][Full Text] [Related]
38. The fatty acid composition of chylomicron remnants influences their binding and internalization by isolated hepatocytes.
Lambert MS; Avella MA; Berhane Y; Shervill E; Botham KM
Eur J Biochem; 2001 Jul; 268(14):3983-92. PubMed ID: 11453992
[TBL] [Abstract][Full Text] [Related]
39. Binding of low-density lipoprotein and chylomicron remnants to the hepatic low-density lipoprotein receptor of dogs, rats and rabbits demonstrated by ligand blotting. Failure to detect a distinct chylomicron-remnant-binding protein by ligand blotting.
Wade DP; Knight BL; Soutar AK
Eur J Biochem; 1986 Sep; 159(2):333-40. PubMed ID: 3019686
[TBL] [Abstract][Full Text] [Related]
40. Receptor-mediated mechanisms of lipoprotein remnant catabolism.
Chappell DA; Medh JD
Prog Lipid Res; 1998 Dec; 37(6):393-422. PubMed ID: 10209655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
